202 related articles for article (PubMed ID: 30662568)
1. Direct
Xiang M; Lu M; Quan J; Xu M; Meng D; Cui A; Li N; Liu Y; Lu P; Kang X; Wang X; Sun N; Zhao M; Liang Q; Le L; Wang X; Zhang J; Chen S
Theranostics; 2019; 9(1):290-310. PubMed ID: 30662568
[TBL] [Abstract][Full Text] [Related]
2. Cells derived from iPSC can be immunogenic - yes or no?
Cao J; Li X; Lu X; Zhang C; Yu H; Zhao T
Protein Cell; 2014 Jan; 5(1):1-3. PubMed ID: 24474200
[TBL] [Abstract][Full Text] [Related]
3. Enhanced wound healing promotion by immune response-free monkey autologous iPSCs and exosomes vs. their allogeneic counterparts.
Lu M; Peng L; Ming X; Wang X; Cui A; Li Y; Wang X; Meng D; Sun N; Xiang M; Chen S
EBioMedicine; 2019 Apr; 42():443-457. PubMed ID: 30926422
[TBL] [Abstract][Full Text] [Related]
4. An Ethanol Extract of
Kim A; Baek SJ; Shin S; Lee SY; Chung SK
Nutrients; 2023 May; 15(10):. PubMed ID: 37242247
[TBL] [Abstract][Full Text] [Related]
5. Tumor-Free Transplantation of Patient-Derived Induced Pluripotent Stem Cell Progeny for Customized Islet Regeneration.
El Khatib MM; Ohmine S; Jacobus EJ; Tonne JM; Morsy SG; Holditch SJ; Schreiber CA; Uetsuka K; Fusaki N; Wigle DA; Terzic A; Kudva YC; Ikeda Y
Stem Cells Transl Med; 2016 May; 5(5):694-702. PubMed ID: 26987352
[TBL] [Abstract][Full Text] [Related]
6. Immunogenicity of induced pluripotent stem cells.
Zhao T; Zhang ZN; Rong Z; Xu Y
Nature; 2011 May; 474(7350):212-5. PubMed ID: 21572395
[TBL] [Abstract][Full Text] [Related]
7. Negligible immunogenicity of terminally differentiated cells derived from induced pluripotent or embryonic stem cells.
Araki R; Uda M; Hoki Y; Sunayama M; Nakamura M; Ando S; Sugiura M; Ideno H; Shimada A; Nifuji A; Abe M
Nature; 2013 Feb; 494(7435):100-4. PubMed ID: 23302801
[TBL] [Abstract][Full Text] [Related]
8. The tumourigenicity of iPS cells and their differentiated derivates.
Liu Z; Tang Y; Lü S; Zhou J; Du Z; Duan C; Li Z; Wang C
J Cell Mol Med; 2013 Jun; 17(6):782-91. PubMed ID: 23711115
[TBL] [Abstract][Full Text] [Related]
9. Molecular imaging of induced pluripotent stem cell immunogenicity with in vivo development in ischemic myocardium.
Liu Z; Wen X; Wang H; Zhou J; Zhao M; Lin Q; Wang Y; Li J; Li D; Du Z; Yao A; Cao F; Wang C
PLoS One; 2013; 8(6):e66369. PubMed ID: 23840453
[TBL] [Abstract][Full Text] [Related]
10. Rapid generation of secondary fibroblasts through teratoma formation.
Cho SM; Park JS; Min B; Kwon S; Kang YK
Biotechniques; 2015 Jul; 59(1):34-41. PubMed ID: 26156782
[TBL] [Abstract][Full Text] [Related]
11. Generation of engraftable hematopoietic stem cells from induced pluripotent stem cells by way of teratoma formation.
Suzuki N; Yamazaki S; Yamaguchi T; Okabe M; Masaki H; Takaki S; Otsu M; Nakauchi H
Mol Ther; 2013 Jul; 21(7):1424-31. PubMed ID: 23670574
[TBL] [Abstract][Full Text] [Related]
12. Distinctive Clinical and Pathologic Features of Immature Teratomas Arising from Induced Pluripotent Stem Cell-Derived Beta Cell Injection in a Diabetes Patient.
Han L; He H; Yang Y; Meng Q; Ye F; Chen G; Zhang J
Stem Cells Dev; 2022 Mar; 31(5-6):97-101. PubMed ID: 35018826
[TBL] [Abstract][Full Text] [Related]
13. Ethanol extract of Magnoliae cortex (EEMC) limits teratoma formation of pluripotent stem cells by selective elimination of undifferentiated cells through the p53-dependent mitochondrial apoptotic pathway.
Kim A; Lee SY; Seo CS; Chung SK
Phytomedicine; 2020 Apr; 69():153198. PubMed ID: 32151917
[TBL] [Abstract][Full Text] [Related]
14. Assessment of iPSC teratogenicity throughout directed differentiation toward an alveolar-like phenotype.
Mitchell A; Wanczyk H; Jensen T; Finck C
Differentiation; 2019; 105():45-53. PubMed ID: 30711828
[TBL] [Abstract][Full Text] [Related]
15. Genetic background affects induced pluripotent stem cell generation.
Schnabel LV; Abratte CM; Schimenti JC; Southard TL; Fortier LA
Stem Cell Res Ther; 2012 Aug; 3(4):30. PubMed ID: 22862934
[TBL] [Abstract][Full Text] [Related]
16. Caffeic acid selectively eliminates teratogenic human-induced pluripotent stem cells via apoptotic cell death.
Kim A; Lee SY; Chung SK
Phytomedicine; 2022 Jul; 102():154144. PubMed ID: 35537368
[TBL] [Abstract][Full Text] [Related]
17. Differentiation and transplantation of functional pancreatic beta cells generated from induced pluripotent stem cells derived from a type 1 diabetes mouse model.
Jeon K; Lim H; Kim JH; Thuan NV; Park SH; Lim YM; Choi HY; Lee ER; Kim JH; Lee MS; Cho SG
Stem Cells Dev; 2012 Sep; 21(14):2642-55. PubMed ID: 22512788
[TBL] [Abstract][Full Text] [Related]
18. Induced Pluripotent Stem Cell (iPSC)-Derived Extracellular Vesicles Are Safer and More Effective for Cardiac Repair Than iPSCs.
Adamiak M; Cheng G; Bobis-Wozowicz S; Zhao L; Kedracka-Krok S; Samanta A; Karnas E; Xuan YT; Skupien-Rabian B; Chen X; Jankowska U; Girgis M; Sekula M; Davani A; Lasota S; Vincent RJ; Sarna M; Newell KL; Wang OL; Dudley N; Madeja Z; Dawn B; Zuba-Surma EK
Circ Res; 2018 Jan; 122(2):296-309. PubMed ID: 29118058
[TBL] [Abstract][Full Text] [Related]
19. Prunellae Spica Extract Suppresses Teratoma Formation of Pluripotent Stem Cells through p53-Mediated Apoptosis.
Kim A; Lee SY; Seo CS; Chung SK
Nutrients; 2020 Mar; 12(3):. PubMed ID: 32182802
[TBL] [Abstract][Full Text] [Related]
20. Induced pluripotent stem cell-derived gamete-associated proteins incite rejection of induced pluripotent stem cells in syngeneic mice.
Kim EM; Manzar G; Zavazava N
Immunology; 2017 Jun; 151(2):191-197. PubMed ID: 28185259
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
